AstraZeneca PLC AZN shares advanced 1.83% to £99.03 Friday, on what proved to be an all-around poor trading session for the ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Drug maker has yet to elaborate whether Leon Wang is in custody, nor have his whereabouts been disclosed AstraZeneca's China ...

One of the highlights is the LOGOS study where South Africa is a global top recruiter (ex China ... positions the country as a key player in AstraZeneca's global strategy. As the company deepens its ...

AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating ...

AstraZeneca Plc said its experimental obesity ... of their body weight over four weeks in an early study, the UK pharma company reported at the ObesityWeek conference in San Antonio, Texas.

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-1.36%decrease ... example of how government scrutiny can hit corporate leadership and dent profits.